PATENT CLAIM ANALYSIS

Application Number: 15971616
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["424", "489000"]

Abstract:
This invention is directed to reduction of flake-like aggregation in nanoparticulate compositions. Also encompassed by the invention are compositions comprising a nanoparticulate active agent, at least one surface stabilizer and a flake-like aggregation reducing agent, such as a buffer and a sugar. The nanoparticulate active agent compositions comprise particles of the active agent having an effective average particle size of less than about 2000 nm.

Claim (Index 40):
A method of administering the injectable, nanoparticulate meloxicam composition of  claim 24  to a human comprising intravenously injecting the composition into the human.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 93.0
- Lexical Diversity: 1.45833
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15130396', '15130331', '15130255', '14133191', '10851661']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8308220146019453
- 35 USC 102 Novelty (BERT): 0.6054822537661517
- Combined Prediction Score: 0.808288038518366
- Mean Citation Score: 536.276146
- Max Citation Score: 583.5876
- Similarity Product: 354.1598910914898

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test